Mar 12, 20192 minAcesion Pharma receives 5M DKK from Innovation Fund Denmark to support human Proof-of-Concept study Acesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most...
Nov 5, 20182 minAcesion Pharma Announces Positive Results for Novel Drug Targeting Atrial FibrillationAcesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most...
Mar 12, 20182 minAcesion Pharma Commences Phase 1 Study in Atrial FibrillationAcesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most...